April 1st 2025
Novavax’s COVID-19 vaccine, Merck’s RSV antibody, and Innoviva’s gonorrhea antibiotic await regulatory decisions this quarter.
Hepatitis A Outbreaks Spotlight Importance of Vaccinations, Risk-Factor Awareness
August 27th 2019No one knows exactly why thousands of patients in dozens of states have contracted hepatitis A in recent years. In the absence of an explanation, public health officials are focusing on vaccination.
Read More
Border Patrol Stance on Flu Vaccines Mobilizes ID Community
August 23rd 2019Three children in US Customs and Border Protection custody have died since December 2018, partially due to influenza. Now, the infectious disease community is rallying for vaccination for migrants in detention facilities.
Read More
Australian Cohort Study: 1 Dose of HPV Vaccine as Effective as 2 or 3 Doses
July 31st 2019The adjusted hazard ratios for 1-dose and 2-dose recipients were comparable to the 3-dose recipients (1 dose 1.01 [95%CI 0.81–1.26], 2 doses 1.00 [0.85–1.17]) after adjusting for age at vaccination among the vaccinated group.
Read More
William Schaffner, MD, Shares Highlights From NFID Annual Conference on Vaccinology Research
April 5th 2019Contagion® caught up with William Schaffner, MD, medical director of the National Foundation for Infectious Diseases, to discuss the highlights from this week’s NFID Annual Conference on Vaccinology Research.
Read More